Impact of Draining Significant Effusion on Gas Exchange and Lung Mechanics in Patient Under Mechanical Ventilation

NCT ID: NCT03394872

Last Updated: 2018-01-09

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

27 participants

Study Classification

OBSERVATIONAL

Study Start Date

2016-05-01

Study Completion Date

2017-08-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Patients with acute respiratory failure (ARF) who were receiving mechanical ventilator support, had significant pleural effusion (both transudates and exudates) and drainage plan were evaluated. Decision to drain, timing and duration of drainage were made by primary physician according to the intensive care unit (ICU) protocols.The estimated amount of effusion (mL) was calculated as the maximum pleura-lung distance (mm) x 20 and significant effusion is accepted as ≥ 800 mL according to thoracic ultrasonography (USG) performed by the intensivist. The amount of effusion drained, mechanical ventilator parameters, arterial blood gas results and hemodynamic data were recorded before, at the 1st hour and at the end of drainage up to 30 days after drainage.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Respiration, Artificial Pleural Effusion Ultrasonography

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Drainage group

Patients under mechanical ventilator support due to acute respiratory failure who had significant pleural effusion and drainage plan according to the intensive Care Unit (ICU) protocols decided by primary physician

Drainage of the pleural effusion

Intervention Type PROCEDURE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Drainage of the pleural effusion

Intervention Type PROCEDURE

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Thoracic Ultrasonography performed by USG certificated intensivist to the all subjects included in the study before drainage

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients on mechanical ventilation due to acute respiratory failure
* Estimated effusion \> 800 ml according to USG
* Have drainage plan according to ICU protocols decided by primary physician

Exclusion Criteria

* Have absolute drainage indication (empyema, hemothorax or chylothorax)
* predicted duration of mechanical ventilation less than 72 hours
* contraindications to drainage,
* underlying disease, which prevents lung expansion (chest deformity, central atelectasis)
* malignant effusions
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Dokuz Eylul University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Begum Ergan

Staff pulmonologist and intensivist in Department Pulmonary and Critical Care Medicine in Dokuz Eylul Universty Hospital, Dokuz Eylul University

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Barış Yılmaz, MD

Role: STUDY_CHAIR

Fellow of Critical Care in Department of Pulmonary and Critical Care Medicine in Dokuz Eylül University

Tuğçe Yılmaz, MD

Role: STUDY_CHAIR

Fellow of Critical Care in Department of Neurology and Critical Care Medicine in Dokuz Eylül University

Begum Ergan, MD

Role: PRINCIPAL_INVESTIGATOR

Staff in Department of Pulmonary and Critical Care Medicine in Dokuz Eylül University

Necati Gokmen, MD

Role: STUDY_DIRECTOR

Staff in Department of Anesthesiology and Critical Care Medicine in Dokuz Eylül University

Kutlay Aydin, MD

Role: STUDY_CHAIR

Fellow of Critical Care in Department of Anesthsiology and Critical Care Medicine in Dokuz Eylül University

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2496-GOA

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.